Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 2 Study of XL184 (Cabozantinib) in Combination with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas

Miscellaneous

Miscellaneous
II
Das, Satya
NCT04079712
VICCNCIGI10315ET-CT


A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

Multiple Cancer Types

Bladder, Kidney (Renal Cell), Rectal
II
Davis, Nancy
NCT03866382
ALLIANCEUROA031702

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: